ARCHIVES

Amgen Cancels Rilotumumab Trials in Gastric Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

NIH Drops Objections To Bill For Research On Environmental Causes of Breast Cancer.

May 23, 2008

Deep Budget Cuts Poised to Kick in March 1; Hill Insiders See Little Hope for Deal

February 15, 2013

Clinical Trials: Data Manager Falsified NSABP Records On 3 Patients, ORI Says

February 12, 1999

Small Study: Radiation, Chemo May Better Control Anal Cancer

November 26, 2010

Senate confirms Crawford as FDA commissioner.

July 22, 2005

NCAB Grants Three MERIT Awards; Rimer To Leave NCI For Post At UNC

June 21, 2002